Cambridge Design Partnership develops new uterine balloon tamponade (UBT) device
Cambridge Design Partnership has announced the development of a new novel uterine balloon tamponade (UBT) to control postpartum haemorrhage…
By
MDBR Staff Writer
All Articles
SetPoint Medical selects Sagentia as development partner for new neuromodulation device
US-based SetPoint Medical has selected Sagentia as a development partner for its neuromodulation device indicated for chronic inflammatory disease.
ByFDA approves GE Healthcare’s brain imaging drug for detection of beta amyloid
GE Healthcare has announced the US Food and Drug Administration (FDA) approval for Vizamyl (Flutemetamol F18 injection), a radioactive…
ByLumenis to launch new FiberLase GYN handpiece set for gynaecological surgery
Lumenis, a developer of medical laser equipment for the surgical and ophthalmology markets, has announced plans to introduce a…
By